- Benzinga
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
The U.S. government will provide up to $75 million to expand U.K.-listed Croda International Plc's (OTC: COIHF) U.S. manufacturing capacity of ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines. Croda will also invest up to $58 million. The investment will be used to establish a new lipid facility in Lamar, Pennsylvania. Construction is expected to start later this year, with the new capacity anticipated in 2025. The investment supports the expansion of Croda's
